These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31521588)

  • 1. Advancing pharmacist prescribing privileges: Is it time?
    Majercak KR
    J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Continuum of Pharmacist Prescriptive Authority.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2016 Sep; 50(9):778-84. PubMed ID: 27307413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.
    Kumar A; Ray AB; Blanchard C
    Health Res Policy Syst; 2022 Jan; 20(1):1. PubMed ID: 34980147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists as mid-level practitioners/providers.
    Ross LA
    Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways to pharmacist prescriptive authority: Do decentralized models for expanded prescribing work?
    Adams AJ; Frost TP
    Res Social Adm Pharm; 2022 Apr; 18(4):2695-2699. PubMed ID: 34321187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
    Wong SL; Barner JC; Sucic K; Nguyen M; Rascati KL
    J Am Pharm Assoc (2003); 2017; 57(3):375-381. PubMed ID: 28506398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
    Burns AL
    Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-managed patient-care services and prescriptive authority in the U.S. Public Health Service.
    Herrier RN; Boyce RW; Apgar DA
    Hosp Formul; 1990 Jan; 25(1):67-8, 76-8, 80. PubMed ID: 10103538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration and compensation of pharmacists into primary care medical groups.
    Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
    J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-prescribed hormonal contraception: A review of the current landscape.
    Tak CR; Kessler LT; Scott MA; Gunning KM
    J Am Pharm Assoc (2003); 2019; 59(5):633-641. PubMed ID: 31300307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
    Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
    Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bills as Band-Aids: Hopes and Challenges of Expanding Pharmacists' Prescriptive Authority to Include Contraceptives.
    Bendtsen K
    HEC Forum; 2019 Dec; 31(4):295-304. PubMed ID: 31396763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements.
    American Pharmacists Association Foundation and American Pharmacists Association
    J Am Pharm Assoc (2003); 2013; 53(2):e132-41. PubMed ID: 23571636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist independent prescribing in secondary care: opportunities and challenges.
    Bourne RS; Baqir W; Onatade R
    Int J Clin Pharm; 2016 Feb; 38(1):1-6. PubMed ID: 26613738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing pharmacist and clinician perspectives on pharmacist-prescribed hormonal contraceptives.
    Whalen A; Bratberg J; Cohen L; Orr K; Lemay V
    J Am Pharm Assoc (2003); 2024; 64(1):314-320.e3. PubMed ID: 37967721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable administration privileges among pharmacists in the United States.
    Oji V; McKoy-Beach Y; Pagan T; Matike B; Akiyode O
    Am J Health Syst Pharm; 2012 Nov; 69(22):2002-5. PubMed ID: 23135568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.